Sabra Healthcare REIT Inc (SBRA)

Currency in USD
19.25
-0.30(-1.53%)
Closed·
19.250.00(0.00%)
·
SBRA Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
High dividend Yield
SBRA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
19.2319.70
52 wk Range
15.6020.03
Key Statistics
Prev. Close
19.55
Open
19.54
Day's Range
19.23-19.7
52 wk Range
15.6-20.03
Volume
2.02M
Average Volume (3m)
2.56M
1-Year Change
17.56%
Book Value / Share
11.4
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SBRA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
20.36
Upside
+5.79%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Sabra Healthcare REIT Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Sabra Healthcare REIT Inc Company Profile

Sabra Health Care REIT, Inc. as of March 31, 2025 investment portfolio included 364 real estate properties held for investment (consisting of (i) 224 skilled nursing/transitional care facilities, (ii) 39 senior housing communities (senior housing - leased), (iii) 69 senior housing communities operated by third-party property managers pursuant to property management agreements (senior housing - managed), (iv) 17 behavioral health facilities and (v) 15 specialty hospitals and other facilities), 15 investments in loans receivable (consisting of three mortgage loans and 12 other loans), four preferred equity investments and two investments in unconsolidated joint ventures. As of March 31, 2025, Sabras real estate properties held for investment included 37,075 beds/units, spread across the United States and Canada.

Sabra Healthcare REIT Inc SWOT Analysis


Healthcare REIT Leade
Sabra Health Care REIT, a $4.33B market cap company, shows resilience in post-pandemic landscape with 10.76% revenue growth and strong portfolio performance
Financial Outlook
Core FFO guidance of $1.43-$1.46 per share for 2025, with AFFO projected at $1.47-$1.50, showcasing stable financial performance and growth potential
Strategic Expansion
Explore Sabra's $200M pipeline of SHOP deals and its focus on senior housing assets, potentially driving multiple expansion and capitalizing on market demand
Analyst Perspectives
Price targets of $20 from Citizens Bank and JMP Securities highlight positive outlook, with potential upside from current trading levels below fair value
Read full SWOT analysis

Sabra Healthcare REIT Inc Earnings Call Summary for Q2/2025

  • Sabra Healthcare REIT reported Q2 2025 EPS of $0.27, surpassing forecasts by 50%, with revenue of $189.15M exceeding expectations by 4.2%
  • Company updated 2025 guidance, projecting net income of $0.77-$0.79 per share and FFO of $1.52-$1.54 per share
  • Sabra targets $1B investment to expand SHOP portfolio to 30%, focusing on strategic transitions and expansions in senior housing
  • Stock closed 1.06% lower at $18.41 post-earnings, but saw 2.55% premarket uptick; maintains 6.52% dividend yield
  • CEO Rick Matros highlighted strong market positioning, with the company actively pursuing asset acquisitions
Last Updated: 05/08/2025, 20:04
Read Full Transcript

Compare SBRA to Peers and Sector

Metrics to compare
SBRA
Peers
Sector
Relationship
P/E Ratio
25.6x16.1x8.9x
PEG Ratio
0.11−0.550.01
Price/Book
1.7x1.3x0.9x
Price / LTM Sales
6.3x4.9x4.0x
Upside (Analyst Target)
8.5%8.0%10.9%
Fair Value Upside
Unlock−8.0%−0.5%Unlock

Analyst Ratings

6 Buy
7 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 20.36
(+5.79% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.77%
Dividend Yield
6.14%
Industry Median 4.88%
Annualised payout
1.20
Paid quarterly
5-Years Growth
-6.17%
Growth Streak

Earnings

Latest Release
Aug 04, 2025
EPS / Forecast
0.27 / 0.18
Revenue / Forecast
189.15M / 181.53M
EPS Revisions
Last 90 days

SBRA Income Statement

People Also Watch

17.65
DOC
-0.56%
42.03
OHI
-0.54%
115.41
CALM
-0.54%
58.21
O
-1.21%
71.10
NEM
+0.47%

FAQ

What Stock Exchange Does Sabra Trade On?

Sabra is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Sabra?

The stock symbol for Sabra is "SBRA."

What Is the Sabra Market Cap?

As of today, Sabra market cap is 4.63B.

What Is Sabra's Earnings Per Share (TTM)?

The Sabra EPS (TTM) is 0.77.

When Is the Next Sabra Earnings Date?

Sabra will release its next earnings report on 29 Oct 2025.

From a Technical Analysis Perspective, Is SBRA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Sabra Stock Split?

Sabra has split 0 times.

How Many Employees Does Sabra Have?

Sabra has 50 employees.

What is the current trading status of Sabra (SBRA)?

As of 25 Aug 2025, Sabra (SBRA) is trading at a price of 19.25, with a previous close of 19.55. The stock has fluctuated within a day range of 19.23 to 19.70, while its 52-week range spans from 15.60 to 20.03.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.